Drug Repurposing: Deferasirox Inhibits the Anti-Apoptotic Activity of Mcl-1.
Asma Bourafai-AziezMohammed BenabderrahmaneHippolyte PaysantLouis-Bastien WeiswaldLaurent PoulainLudovic CarlierDelphine RavaultMarie JouanneGaël CoadouHassan OulyadiAnne-Sophie Voisin-ChiretJana Sopková-de Oliveira SantosMuriel SebbanPublished in: Drug design, development and therapy (2021)
Deferasirox could be a potential candidate for drug repositioning as Mcl-1 inhibitor.
Keyphrases